Answers are grounded in this paper and cite their sources.
DRibble vaccine given with GM-CSF appeared safe and capable of inducing an immune response against tumor cells in this small, pilot study. There was no evidence of efficacy in this small poor-prognosis patient population, with treatment not feasible. Trial registration NCT00850785, initial registration date February 23, 2009.
No takes yet. Share an insight, caveat, or question.
Sanborn et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: